Tumor-selective replication herpes simplex virus-based technology significantly improves clinical detection and prognostication of viable circulating tumor cells

Published 2016 View Full Article

Authors

Keywords

viable circulating tumor cells, epithelial-marker-independent, telomerase-specific HSV, clinical application

Journal

Oncotarget

Volume 7, Issue 26, Pages -

Publisher

Impact Journals, LLC

Online

2016-05-20

DOI

10.18632/oncotarget.9465

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started